Cargando…
Military use of drugs not yet approved by the FDA for CW/BW defense : lessons from the Gulf War /
The confrontation that began when Iraq invaded Kuwait in August 1990 brought with it the threat that chemical and biological weapons might be used against the more than half a million military personnel the United States deployed to the region. To protect these troops from such threats, the Departme...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Autores Corporativos: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Santa Monica, Calif. :
RAND,
1999.
|
| Colección: | Gulf War illnesses series.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | EBSCO_ocm44963321 | ||
| 003 | OCoLC | ||
| 005 | 20231017213018.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 000807s1999 cau ob 000 0 eng d | ||
| 010 | |a 98031679 | ||
| 040 | |a N$T |b eng |e pn |c N$T |d OCL |d OCLCQ |d TUU |d OCLCQ |d TNF |d COO |d OCLCO |d NUI |d UBY |d CLU |d OCLCO |d OCLCQ |d OCLCA |d ZCU |d OCLCA |d OCLCQ |d OCLCO |d NLGGC |d OCLCQ |d NAM |d UAT |d OCLCF |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d AZK |d OCLCO |d CUS |d OCLCQ |d OCLCO |d MWM |d AGLDB |d TOA |d CPO |d PLS |d OCLCQ |d SAV |d QT7 |d OCLCO |d OCLCQ |d OCLCO |d BUF |d LUE |d OCLCO |d OCL |d OCLCO |d VNS |d WRM |d OCLCO |d VTS |d CEF |d OCLCQ |d OCLCO |d INT |d TOF |d OCLCQ |d WYU |d S9I |d TKN |d GDC |d STF |d OCLCO |d U3G |d M8D |d JZ6 |d OCL |d UKSSU |d VLY |d CLU |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d WGGTC |d TEU |d OCL |d OCLCO | ||
| 019 | |a 233156687 |a 532652777 |a 855304052 |a 961599909 |a 962682688 |a 1038554344 |a 1044514038 |a 1060914855 |a 1067163722 |a 1073083152 |a 1162439735 |a 1241827022 |a 1253384320 |a 1327488878 |a 1373101388 | ||
| 020 | |a 0585245479 |q (electronic bk.) | ||
| 020 | |a 9780585245478 |q (electronic bk.) | ||
| 020 | |a 9780833026835 |q (v. 9) | ||
| 020 | |a 0833026836 |q (v. 9) | ||
| 020 | |z 0833026836 |q (pbk.) | ||
| 027 | |a RAND/MR-1018/9-OSD | ||
| 029 | 1 | |a AU@ |b 000051333343 | |
| 029 | 1 | |a DEBBG |b BV043071983 | |
| 029 | 1 | |a DEBSZ |b 422551503 | |
| 029 | 1 | |a GBVCP |b 800642791 | |
| 035 | |a (OCoLC)44963321 |z (OCoLC)233156687 |z (OCoLC)532652777 |z (OCoLC)855304052 |z (OCoLC)961599909 |z (OCoLC)962682688 |z (OCoLC)1038554344 |z (OCoLC)1044514038 |z (OCoLC)1060914855 |z (OCoLC)1067163722 |z (OCoLC)1073083152 |z (OCoLC)1162439735 |z (OCoLC)1241827022 |z (OCoLC)1253384320 |z (OCoLC)1327488878 |z (OCoLC)1373101388 | ||
| 037 | |c $20.00 | ||
| 043 | |a n-us--- |a ap----- |a a-iq--- | ||
| 050 | 4 | |a UG447 |b .R46 1999eb | |
| 072 | 7 | |a HIS |x 027010 |2 bisacsh | |
| 082 | 0 | 4 | |a 358/.34 |2 21 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Rettig, Richard A. | |
| 245 | 1 | 0 | |a Military use of drugs not yet approved by the FDA for CW/BW defense : |b lessons from the Gulf War / |c Richard A. Rettig. |
| 260 | |a Santa Monica, Calif. : |b RAND, |c 1999. | ||
| 300 | |a 1 online resource (xx, 102 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file | ||
| 347 | |b PDF | ||
| 490 | 1 | |a Gulf War illnesses series | |
| 500 | |a "Prepared for the Office of the Secretary of Defense, National Defense Research Institute." | ||
| 500 | |a "MR-1018-9-OSD"--Page 4 of cover | ||
| 504 | |a Includes bibliographical references (pages 99-102). | ||
| 520 | |a The confrontation that began when Iraq invaded Kuwait in August 1990 brought with it the threat that chemical and biological weapons might be used against the more than half a million military personnel the United States deployed to the region. To protect these troops from such threats, the Department of Defense wished to use drugs and vaccines that, not having been tested for use in these specific situations, were considered "investigational" by the federal Food and Drug Administration. This report examines the history of the Interim Rule, adopted in December 21, 1990, that authorized the Commissioner of Food and Drugs to waive informed consent for the use of investigational drugs and vaccines for certain military uses; how this authority was used for pyridostigmine bromide and botulinum toxoid during the Gulf War; and the subsequent controversy surrounding the rule, its application, and its implications. The report then analyzes the issues the Interim Rule raised when investigational drugs are used for such purposes and makes recommendations for dealing with similar situations in the future. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Ch. 1. Introduction -- Purpose and Organization -- Background -- The Issues -- The Text of the Interim Rule -- Ch. 2. The History of the Interim Rule -- The Memorandum of Understanding Between DoD and FDA -- Careful Deliberations: 1990 -- Litigation: 1991 -- Actual Gulf War Experience with PB, BT and AX -- The Presidential Advisory Committee -- Ch. 3. What Uses of Drugs are Investigational? -- The Experiment-Therapy Continuum -- The Belmont Report -- Ethical Considerations -- FDA's Approach to the Definitional Task -- Ch. 4. The Interim Rule and Its Alternatives -- Issues Associated with the Interim Rule -- Alternatives to the Interim Rule -- Ch. 5. Broader Issues -- Internal DoD Issues -- The Question of Authority -- Interactions Between DoD and FDA -- Ch. 6. Conclusions and Recommendations -- Ch. 7. Postscript. | |
| 546 | |a English. | ||
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 610 | 1 | 2 | |a United States |b Food and Drug Administration |
| 650 | 0 | |a Chemical warfare |x Security measures. | |
| 650 | 0 | |a Biological warfare |x Security measures. | |
| 650 | 0 | |a Gases, Asphyxiating and poisonous |x Antagonists. | |
| 650 | 0 | |a Vaccines. | |
| 650 | 0 | |a Informed consent (Medical law) |z United States. | |
| 650 | 0 | |a Involuntary treatment |z United States. | |
| 651 | 0 | |a United States |x Armed Forces |x Medical care. | |
| 650 | 0 | |a Persian Gulf War, 1991 |x Chemical warfare. | |
| 650 | 2 | |a Vaccines | |
| 650 | 6 | |a Guerre chimique |x Sécurité |x Mesures. | |
| 650 | 6 | |a Guerre biologique |x Sécurité |x Mesures. | |
| 650 | 6 | |a Gaz asphyxiants et délétères |x Antagonistes. | |
| 650 | 6 | |a Vaccins. | |
| 650 | 6 | |a Consentement éclairé (Droit médical) |z États-Unis. | |
| 650 | 6 | |a Traitement non volontaire (Thérapeutique) |z États-Unis. | |
| 650 | 6 | |a Guerre du golfe Persique, 1991 |x Guerre chimique. | |
| 650 | 7 | |a HISTORY |x Military |x Biological & Chemical Warfare. |2 bisacsh | |
| 650 | 7 | |a Medicine, Military |2 fast | |
| 650 | 7 | |a Armed Forces |x Medical care |2 fast | |
| 650 | 7 | |a Biological warfare |x Security measures |2 fast | |
| 650 | 7 | |a Chemical warfare |2 fast | |
| 650 | 7 | |a Chemical warfare |x Security measures |2 fast | |
| 650 | 7 | |a Informed consent (Medical law) |2 fast | |
| 650 | 7 | |a Involuntary treatment |2 fast | |
| 650 | 7 | |a Vaccines |2 fast | |
| 651 | 7 | |a Middle East |2 fast | |
| 651 | 7 | |a United States |2 fast | |
| 647 | 7 | |a Persian Gulf War |d (1991) |2 fast |0 (OCoLC)fst01058380 | |
| 648 | 7 | |a 1991 |2 fast | |
| 710 | 1 | |a United States. |b Department of Defense. |b Office of the Secretary of Defense. | |
| 710 | 2 | |a National Defense Research Institute (U.S.) | |
| 776 | 0 | 8 | |i Print version: |a Rettig, Richard A. |t Military use of drugs not yet approved by the FDA for CW/BW defense. |d Santa Monica, Calif. : RAND, 1999 |z 0833026836 |w (DLC) 00502281 |w (OCoLC)41536148 |
| 830 | 0 | |a Gulf War illnesses series. | |
| 856 | 4 | 0 | |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=20478 |z Texto completo |
| 936 | |a BATCHLOAD | ||
| 938 | |a EBSCOhost |b EBSC |n 20478 | ||
| 994 | |a 92 |b IZTAP | ||